Home : Health : Healthy Living :

Healthy Living

Boost your capacity to cope

We know that we're likely to melt down when things get hectic, …

FDA warns of infections tied to pharm.

The Food and Drug Administration said Friday that the …

Stress may be causing your cravings

Drugs, food and habitual behaviors all have a direct effect on …

You eat more calories than you think

"At least two-thirds of all (study) participants underestimated…

McDonald's can't shake criticism about nutrition

McDonald's still rapped over nutrition

McDonald's was taken to task by speakers associated with an …

FDA OKS Lucentis for diabetes-related eye disorder

Condition can cause blindness

Updated: Friday, 10 Aug 2012, 4:29 PM EDT
Published : Friday, 10 Aug 2012, 4:29 PM EDT

The Associated Press

WASHINGTON (AP) - The Food and Drug Administration on Friday approved Roche's injectable eye drug Lucentis for a new use in treating a diabetes-related condition that can cause blindness.

The agency cleared the drug for diabetic macular edema, a condition that causes swelling and blurred vision in patients with diabetes. In 2010, 3.9 million adults with diabetes reported vision problems, according to the FDA.

Lucentis is currently marketed for wet, age-related macular degeneration, the leading cause of blindness among the elderly. The drug has been facing new competition in that market from Regeneron Pharmaceutical's Eylea, which is cheaper and can be administered with fewer injections.

Side effects with Lucentis include bleeding around the tissue that lines the eyelids and increased pressure on the eyes.

Lucentis is manufactured by Roche's Genentech unit

Comments

With WIVB.com's new commenting system you don't need to register. You can login with an existing Facebook, Yahoo!, Google, or Twitter account and more. If you have a WIVB.com login you can still use it in our Participate section.